Skip to content

Prime Medicine PRME Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-216.1%-101pp-146.8%-9.9pp-112.3%+2.0pp-154.8%-55.2pp-115.2%-36.9pp
Return on invested capital-175.4%-38.7pp-138.9%+40.5pp-144.7%+15.8pp-136.8%-10.5pp
Liquidity
Current ratio3.8×-1.0×4.8×-0.7×6.6×+0.1×3.6×-4.7×4.8×-4.1×
Leverage
Debt-to-equity1.5×+0.4×+0.7×0.7×+0.5×+1.8×1.1×+1.0×
Per Share
Book value per share$0.43-47.0%$0.81-37.1%$1.01-36.3%$0.47-71.4%$0.82-65.0%
Valuation
Market capitalization$574.36M+111%$626.37M+63.5%$987.64M+114%$283.6M-53.7%$261.01M-64.3%
Price / book7.5×+4.9×5.2×+2.7×6.1×+3.7×4.7×+1.5×2.4×-0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Prime Medicine's ratios come from?
Every ratio is computed from Prime Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.